Whats new

Whats new.

Canaccord Genuity - Upcoming FDA ODAC meeting puts mounting pressure on Keytruda; Buy, A$0.95 PT (Analyst: Elyse Shapiro)

September 25th 2024

For a copy of this research report please contact your Canaccord Genuity advisor